PATH Vaccine Solutions
Seattle, Washington, United States
Purpose
to develop a controlled human infection model employing a standardized and stable Enterotoxigenic Escherichia coli (ETEC) strain expressing CS6 antigen to accelerate vaccine development for use in developing countries
Division
Global Health
Date
December 2015
Region Served
GLOBAL
Committed amount
$1,103,755
Grant topic
Discovery and Translational Sciences, Enteric and Diarrheal Diseases
Duration (months)
22
Grantee location
Seattle, Washington, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.